IMPURITIES AVAILABLE FOR 'Canertinib Dihydrochloride'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Canertinib Dihydrochloride. Canertinib Dihydrochloride is an orally active, irreversible pan-ErbB receptor tyrosine kinase inhibitor. It targets and blocks epidermal growth factor receptors (EGFR/ErbB1), HER2/ErbB2, and ErbB4, thereby interfering with signaling pathways that regulate cancer cell growth and survival. By covalently binding to the kinase domain, it provides sustained inhibition of receptor activity. Canertinib has been studied for its potential in treating solid tumors, including breast, lung, and head and neck cancers. Its mechanism helps suppress tumor proliferation, angiogenesis, and metastasis. The compound shows promise in overcoming resistance to first-generation EGFR inhibitors. It is usually administered orally in research and clinical trial settings. Adverse effects may include gastrointestinal disturbances, rash, and fatigue, which are common with EGFR-targeted therapies. Buy high quality Canertinib Dihydrochloride from Omsynth Lifesciences.